UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q1 2023 | 2023-08-03 | Future report Set alerts | |
| Q4 2022 | 2023-02-23 | 3.61 | 3.61 |
| Q3 2022 | 2022-11-03 | 2.53 | 2.53 |
| Q2 2022 | 2022-08-03 | 5.24 | 5.24 |
| Q1 2022 | 2022-05-04 | 8.58 | 8.58 |
| Q4 2021 | 2022-02-24 | 11.29 | 11.29 |
| Q3 2021 | 2021-11-04 | 7.70 | 7.70 |
| Q2 2021 | 2021-08-05 | 6.46 | 6.46 |
| Q1 2021 | 2021-05-06 | 2.84 | 2.84 |
| Q4 2020 | 2021-02-25 | -0.69 | -0.69 |
In MRNA 491 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BAILLIE GIFFORD & CO | 45.28M |
| Vanguard Group, Inc | 27.44M |
| BlackRock Inc. | 25.40M |
| STATE STREET CORP | 14.51M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.44M |
| GEODE CAPITAL MANAGEMENT, LLC | 6.25M |
| Theleme Partners LLP | 6.00M |
| COATUE MANAGEMENT LLC | 5.71M |
| WELLINGTON MANAGEMENT CO LLP | 4.71M |
| CITADEL ADVISORS LLC | 4.56M |
| MORGAN STANLEY | 3.52M |
| NORTHERN TRUST CORP | 3.23M |
| BANQUE PICTET & CIE SA | 3.02M |
| BANK OF AMERICA CORP /DE/ | 2.99M |
| GOLDMAN SACHS GROUP INC | 2.90M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Trieu Vuong Chairman of the Board | 43.41% (11127141) | MRNA / SRNE / |
| Novartis Bioventures Ltd | 9.73% (2495065) | AKBA / CLDN / MRNA / PIP / TKAI / |
| Pryor Cashman LLP | 6.21% (1591959) | MRNA / |
| QUAY STEVEN C Chairman, President and CEO | 4.55% (1166504) | ATOS / MRNA / |
| Ranker Philip C Chief Financial Officer | 3.50% (897553) | MRNA / |
| FRENCH J MICHAEL CEO | 3.21% (822283) | MRNA / |
| Ramelli Joseph W. | 1.72% (440653) | MRNA / |
| Ho Richard Theodore Executive V.P. R&D | 1.52% (390000) | MRNA / |
| WENIG DEVIN | 1.19% (305287) | EBAY / MRNA / |
| Loren Stefan | 0.71% (181303) | GNVC / MRNA / |
| THAW BRUCE R/FA | 0.64% (164041) | MRNA / |
| Stanewick Gerald T | 0.45% (116412) | MRNA / |
| Parker Peter | 0.33% (84010) | MRNA / |
| Duffy Timothy M Exec. VP of Business Devp | 0.22% (56395) | MRNA / |
| BRANDT GORDON President | 0.16% (41705) | MRNA / PZRX / |
| CROSS ALEXANDER D | 0.15% (38000) | ATOS / MRNA / |
| YORK BRUCE R Chief Actg Officer, Asst Sec. | 0.14% (35232) | MRNA / |
| JOHNSON PAUL H Sr VP of R&D, CSO | 0.11% (29301) | MRNA / PZRX / |
| HOLUBIAK MYRON Z | 0.10% (26657) | ASMB / BIOS / MRNA / |
| BAYH SUSAN B | 0.10% (24735) | CRIS / DNDN / DYAX / EMMS / MRNA / |
| Costantino Henry R Chief Scientific Officer | 0.09% (24047) | MRNA / |
| GARCIA PETER S Chief Financial Officer | 0.02% (5000) | BTX / MRNA / PDLI / |
UM